IP Library Granted Patent US 10,522,261
Granted Patent B2
US 10,522,261 · App. 15/311,052 · Granted Dec 31, 2019

Solution target for cyclotron production of radiometals

Inventors: Timothy R. DeGrado (Rochester, MN); Mukesh K. Pandey (Rochester, MN); John Byrne (Boston, MA)
Assignees: Mayo Foundation for Medical Education and Research; Brigham and Women's Hospital, Inc.
G21G1/10B01D15/08B01J20/22G21G1/001G21G2001/0021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,522,261
App. No.
15/311,052
Granted
Dec 31, 2019
Kind
B2
Abstract

Methods of producing and isolating 68 Ga, 89 Zr, 64 Cu, 63 Zn, 86 Y, 61 Cu, 99m Tc, 45 Ti, 13 N, 52 Mn, or 44 Sc and solution targets for use in the methods are disclosed. The methods of producing 68 Ga, 89 Zr, 64 Cu, 63 Zn, 86 Y, 61 Cu, 99 mTc, 45 Ti, 13 N, 52 Mn, or 44 Sc include irradiating a closed target system with a proton beam. The closed target system can include a solution target. The methods of producing isolated 68 Ga, 89 Zr, 64 Cu, 63 Zn, 86 Y, 61 CU, 99m TC, 45 -Ti, 52 Mn, or 44 Sc by ion exchange chromatography. An example solution target includes a target body including a target cavity for receiving the target material; a housing defining a passageway for directing a particle beam at the target cavity; a target window for covering an opening of the target cavity; and a coolant gas flow path disposed in the passageway upstream of the target window.

Claims (25)

1. A synthesis system comprising:

a cyclotron operable for bombarding a target material in a target cavity of a solution target with protons or deuterons; and

a kit for isolation of a radionuclide from a solution including the radionuclide, the solution having been produced by the bombarding of the target material in the target cavity of the solution target with protons or deuterons, the kit comprising: a column including a sorbent to adsorb the produced radionuclide on the sorbent, wherein the sorbent comprises a hydroxamate resin; and an eluent for eluting the radionuclide off the sorbent,

wherein the radionuclide is selected from 68 Ga, 89 Zr, 64 Cu, 86 Y, 63 Zn, 61 Cu, 99m TC, 45 Ti, 52 Mn and 44 Sc.

2. The synthesis system of claim 1 , wherein:

the eluent comprises a phosphate.

3. The synthesis system of claim 1 , further comprising:

a radionuclide product vessel for receiving eluted radionuclide from the column.

4. The synthesis system of claim 1 , further comprising:

a first fluid conduit for placing the column in fluid communication with the cyclotron, and

a second fluid conduit for placing the column in fluid communication with the vessel that receives the solution including the eluted radionuclide.

5. The synthesis system of claim 1 , further comprising:

a second column including a sorbent to adsorb impurities in the eluent used for eluting radionuclide from the column.

6. The synthesis system of claim 1 , further comprising:

a controller for automating the system.

7. The synthesis system of claim 6 , wherein:

the controller executes a stored program to: (i) deliver the solution including the radionuclide from the target cavity to the column, (ii) thereafter deliver the eluent to the column, and (iii) thereafter deliver the eluted radionuclide to a radionuclide product vessel.

8. The synthesis system of claim 6 , wherein:

the controller executes a stored program to: (i) deliver the solution including the radionuclide from the target cavity cyclotron to a collection vessel, (ii) deliver the solution including the radionuclide from the collection vessel to the column, (iii) thereafter deliver the eluent to the column, and (iv) thereafter deliver the eluted radionuclide to a radionuclide product vessel.

9. The synthesis system of claim 1 wherein:

the eluent comprises hydrogen phosphate ions.

10. The synthesis system of claim 1 wherein:

the eluent comprises an alkali metal hydrogen phosphate.

11. The synthesis system of claim 1 wherein:

the eluent comprises HCl.

Assignments (4)
CONFIRMATORY LICENSE Recorded Nov 16, 2020
From: MAYO CLINIC ROCHESTER
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 054436/0355 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME BRIGHAM AND WOMEN'S HOSPITAL, INC. PREVIOUSLY RECORDED ON REEL 040718 FRAME 0632. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 11, 2020
From: BYRNE, JOHN
To: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 051893/0667 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2016
From: BYRNE, JOHN
To: BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 040718/0632 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2016
From: DEGRADO, TIMOTHY R.; PANDEY, MUKESH K.
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 040718/0709 →
Continuity (2)
Provisional Application 61993365 · May 15, 2014
Related Publication 20170221594A1 · Aug 3, 2017
Cited By (2)
US 12,527,885 US 12,622,984